Advances in Managing Fistulizing Crohn's Disease
A Multidisciplinary Approach
eReader Download
Apple Books | Amazon | Barnes & Noble | Google Play | Scribd
Guidelines
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
Feuerstein JD, Ho EY, Shmidt E, et al. Gastroenterology. 2021;160(7):2496-2508.
ACG Clinical Guidelines: Management of Crohn's Disease in Adults.
Lichtenstein GR, Loftus EV, Isaacs KL, et al. Am J Gastroenterol. 2018;113(4):481-517.
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
Torres J, Bönovas S, Doherty G, et al. J Crohns Colitis. 2020;14(1):4-22.
American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
Feuerstein JD, Nguyen GC, Kupfer SS, et al. Gastroenterology. 2017;153(3):827-834.
Suggested Readings
Managing complex perianal fistulizing disease.
Pederson KE, Lightner AL. J Laparoendosc Adv Surg Tech A. 2021;31(8):890-897.
Fistulizing Crohn's disease.
Lightner AL, Ashburn JH, Brar MS, et al. Curr Probl Surg. 2020;57(11):100808.
Management of complex perianal Crohn's disease.
Aguilera-Castro L, Ferre-Aracil C, Garcia-Garcia-de-Paredes A, et al. Ann Gastroenterol. 2017;30(1):33-44.
Modern surgical strategies for perianal Crohn's disease.
Zabot GP, Cassol O, Saad-Hossne R, et al. World J Gastroenterol. 2020; 26(42):6572-6581.
Development and initial psychometric validation of a patient-reported outcome measure for Crohn's perianal fistula: the Crohn's anal fistula quality of life (CAF-QoL) scale.
Adegbola SO, Dibley L, Sahnan K, et al. Gut. 2021;70(9):1649-1656.
Treatment algorithms for Crohn's disease.
Sulz MC, Burri E, Michetti P, et al. Digestion. 2020;101(suppl 1):43-57.
Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists
Agrawal M, Spencer EA, Colombel JF, et al. Gastroenterology. 2021;161(1):47-65.
Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease.
Ji CC, Takano S. Intest Res. 2017;15(2):182-186.
Efficacy and safety of 2 vedolizumab intravenous regimens for perianal fistulizing Crohn's disease: ENTERPRISE Study.
Schwartz DA, Peyrin-Biroulet L, Lasch K, et al. Clin Gastroenterol Hepatol. 2022;20(5):1059-1067.
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis.
Ayoub F, Odenwald M, Micic D, et al. Intest Res. 2022;20(2):240-250.
Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature.
Attauabi M, Burisch J, Seidelin JB. Scand J Gastroenterol. 2021;56(1):53-58.
Mesenchymal stromal cell therapy in the management of perianal fistulas in Crohn's disease: an up-to-date review.
Gallo G, Tiesi V, Fulginiti S, et al. Medicina (Kaunas). 2020;56(11):563.
Regenerative medicine for digestive fistulae therapy: benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles.
Sebbagh AC, Rosenbaum B, Péré G, et al. Adv Drug Deliv Rev. 2021;179:113841.
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
Panés J, García-Olmo D, Van Assche G, et al. Lancet. 2016;388(10051):1281-1290.
Follow-up study to evaluate the long-term safety and efficacy of darvadstrocel (mesenchymal stem cell treatment) in patients with perianal fistulizing Crohn's disease: ADMIRE-CD phase 3 randomized controlled trial.
Garcia-Olmo D, Gilaberte I, Binek M, et al. Dis Colon Rectum. 2022;65(5):713-720.
P603 INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s disease and complex perianal fistulas.
Zmora O, Baumgart DC, Faubion W, et al. J Crohn's Colitis. 2022;16(suppl 1):i536-i537.
Patient Resources
American College of Gastroenterology
American Gastroenterological Association
Crohn's and Colitis Foundation
European Crohn's and Colitis Organisation
National Institute of Diabetes and Digestive and Kidney Diseases
Health information for Crohn's disease
A Multidisciplinary Approach
Relevant Resources
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
Got it? Treat it!
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Why It Matters in OB/GYN Practice Today
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
The PCP’s Role in HCV Elimination
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Informing the Future of NASH Diagnosis and Assessment
An Interactive Learning Experience
A Focus on Clinical Evidence and Guideline Recommendations
A Multidisciplinary Online Mini-Curriculum
Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
A Multidisciplinary Look at Early Diagnosis and Management
Best Practices for Diagnosis and Management
Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis
